Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-12-09 Sale | 2025-12-09 7:07 pm | Centessa Pharmaceuticals plc | CNTA | Accardi Mario Alberto President, Orexin Program | 10,000 | $28.83 | $288,289 | 178,801 (Direct) | View |
| 2025-12-08 Sale | 2025-12-08 6:26 pm | Centessa Pharmaceuticals plc | CNTA | Accardi Mario Alberto President, Orexin Program | 10,000 | $30 | $300,000 | 195,051 (Direct) | View |
| 2025-10-27 Sale | 2025-10-27 7:56 pm | Centessa Pharmaceuticals plc | CNTA | Accardi Mario Alberto President, Orexin Program | 8,000 | $25 | $200,000 | 224,394 (Direct) | View |
| 2025-09-16 Sale | 2025-09-16 6:16 pm | Centessa Pharmaceuticals plc | CNTA | Accardi Mario Alberto President, Orexin Program | 8,172 | $21.4 | $174,846 | 197,394 (Direct) | View |
| 2025-09-09 Sale | 2025-09-11 5:45 pm | Centessa Pharmaceuticals plc | CNTA | Accardi Mario Alberto President, Orexin Program | 7,000 | $20 | $140,000 | 240,566 (Direct) | View |
| 2025-07-29 Sale | 2025-07-30 5:00 pm | Centessa Pharmaceuticals plc | CNTA | Accardi Mario Alberto President, Orexin Program | 8,322 | $15.23 | $126,751 | 208,163 (Direct) | View |
| 2025-06-24 Sale | 2025-06-25 7:42 pm | Centessa Pharmaceuticals plc | CNTA | Accardi Mario Alberto President, Orexin Program | 15,000 | $14 | $210,000 | 231,785 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-12-08 Exercise | 2025-12-08 6:26 pm | N/A 2032-02-01 | Centessa Pharmaceuticals plc | CNTA | Accardi Mario Alberto President, Orexin Program | 5,000 | $0 | 195,051 (Direct) | View |
| 2025-12-08 Exercise | 2025-12-08 6:26 pm | N/A N/A | Centessa Pharmaceuticals plc | CNTA | Accardi Mario Alberto President, Orexin Program | 5,000 | $9.53 | 195,051 (Direct) | View |
| 2025-11-01 Tax Withholding | 2025-11-03 4:14 pm | N/A N/A | Centessa Pharmaceuticals plc | CNTA | Accardi Mario Alberto President, Orexin Program | 593 | $24.9 | 193,801 (Direct) | View |
| 2025-10-27 Exercise | 2025-10-27 7:56 pm | N/A 2034-02-01 | Centessa Pharmaceuticals plc | CNTA | Accardi Mario Alberto President, Orexin Program | 5,000 | $0 | 224,394 (Direct) | View |
| 2025-10-27 Exercise | 2025-10-27 7:56 pm | N/A N/A | Centessa Pharmaceuticals plc | CNTA | Accardi Mario Alberto President, Orexin Program | 5,000 | $8.01 | 224,394 (Direct) | View |
| 2025-09-09 Exercise | 2025-09-11 5:45 pm | N/A 2034-02-01 | Centessa Pharmaceuticals plc | CNTA | Accardi Mario Alberto President, Orexin Program | 5,000 | $0 | 240,566 (Direct) | View |
| 2025-09-09 Exercise | 2025-09-11 5:45 pm | N/A N/A | Centessa Pharmaceuticals plc | CNTA | Accardi Mario Alberto President, Orexin Program | 5,000 | $8.01 | 240,566 (Direct) | View |
| 2025-08-01 Tax Withholding | 2025-08-01 5:00 pm | N/A N/A | Centessa Pharmaceuticals plc | CNTA | Accardi Mario Alberto President, Orexin Program | 597 | $17.17 | 207,566 (Direct) | View |
| 2025-06-24 Exercise | 2025-06-25 7:42 pm | N/A 2033-02-01 | Centessa Pharmaceuticals plc | CNTA | Accardi Mario Alberto President, Orexin Program | 15,000 | $0 | 231,785 (Direct) | View |
| 2025-06-24 Exercise | 2025-06-25 7:42 pm | N/A N/A | Centessa Pharmaceuticals plc | CNTA | Accardi Mario Alberto President, Orexin Program | 15,000 | $3.85 | 231,785 (Direct) | View |
Ownership | 2025-06-24 4:08 pm | N/A N/A | Centessa Pharmaceuticals plc | CNTA | Accardi Mario Alberto President, Orexin Program | 0 | $0 | 539,910 (Direct) | View |